Supreme Court Issues Contempt Notice to Patanjali Over Misleading Advertisements

The Supreme Court has issued a contempt notice to Patanjali Ayurved and its Managing Director, Acharya Balkrishna, for disseminating misleading advertisements. This verdict deals a blow to the company co-owned by yoga guru Ramdev, highlighting concerns over the promotion of its products with unverified claims.

Court’s Criticism and Caution Against Misleading Claims

The apex court has restrained Patanjali Ayurved from advertising or branding products that claim to cure specific diseases, cautioning against any statements made against other systems of medicine. The ruling emphasizes the importance of adhering to regulations and refraining from making unverified assertions regarding the efficacy of their products.

Key Quotes from the Hearing

During the proceedings, the court questioned the audacity of Patanjali Ayurved in issuing advertisements that claim “permanent relief” and raise doubts about the products’ ability to cure diseases. The court’s scrutiny extended to Patanjali’s claims of curing ailments like blood pressure, diabetes, arthritis, asthma, and obesity, highlighting the need for accountability and responsibility in advertising practices.

Criticism of Defamation and Allegations Against Allopathy

The court expressed concern over the defamation of allopathy in public perception, cautioning against denigrating other systems of medicine. Additionally, the court addressed the role of Swami Ramdev Baba, acknowledging his contributions to popularizing yoga but cautioning against unwarranted criticism of other medical practices.

Government’s Oversight Under Scrutiny

The verdict also scrutinized the government’s role, questioning the delay in taking action against misleading advertisements despite regulations prohibiting such practices. The court’s rebuke underscores the need for proactive measures to uphold consumer rights and ensure compliance with regulatory standards.
.